When your doctor prescribes an antibiotic course, you can be certain that continuing with your CHD-FA™ supplement is safe. In-fact the great news is that CHD-FA™ will make your antibiotics more effective.
For many years it was believed that antibiotics are a magic cure for everything, but in recent times we’ve learnt that overusing them can be harmful. When antibiotics are overused or used incorrectly (when it’s not truly needed) the bacteria become more resistant to the drug. You’ve probably heard of the term ‘antibiotic resistance’. Our studies have found that it’s not only safe to take CHD-FA™ with antibiotics, but it also increases its efficiency. Let’s take a closer look.
Let’s revise the basic characteristics of CHD-FA™
CarboHydrate Derived Fulvic Acid (CHD-FA™) is a pure form of fulvic acid and is free of:
- Heavy metals like arsenic and lead
- Many environmental pollutants like pesticides and herbicides
CHD-FA™ is a low molecular weight, colloidal material with high solubility in water. Such a pure composition of CHD-Fulvic Acid™ is described as being useful for self-medication of many conditions because it is:
Using CHD-FA™ with Antibiotics
- Peer-reviewed studies have proved that CHD-FA™ is a promising topical therapy for drug-resistant wound infections. It accelerates the healing process of wounds infected with bacteria which can be linked to both of its anti-bacterial and anti-inflammatory properties.
- CHD-FA is a well-known anti-bacterial agent and using antibiotics with CHD-Fulvic Acid™ has proven to be a very effective combination as has been proven in many in-vitro and in-vivo studies.
- It is a known fact that many strains of bacteria are resistant to antibiotics. When these bacterial strains are treated with CHD-FA™ alone, it is effective as a treatment but when the CHD-FA™ is used synergistically with antibiotics; it proves to be a “superior combination” for to effectively treat various conditions. This is proven by work done on CHD-Fulvic Acid™ such as:
- The known synergistic effect of antibiotics like Oxacillin, Gentamycin and Amphotericin B with CHD-FA™ is significant in the treatment of many diseases. The utility of fulvic acid in combination with oxacillin or gentamicin against multiple drug-resistant bacteria is found out to be very effective. 
- Oxacillin: According to research conducted by Dr Peter Warn by Euprotec in February 2009 claimed that it acts synergistically with the Oxacillin and is very effective against the treatment of many resistant strains of bacteria. 
- Gentamicin: Using of CHD-FA™ with Gentamicin also generates results of the considerably best combination for the treatment of multiple drug-resistant bacteria.
- Amphotericin B: Amphotericin B is an antibiotic that targets fungi. This drug is used in very lower doses for the treatment of visceral leishmaniasis. The higher dose of Amphotericin B is toxic to humans. A non-toxic dose of Amphotericin B along with CHD-FA™ is used for the treatment, and it comes out to be a very effective combination for the treatment of patients for a longer time without causing any toxicity.
What does this all mean?
Using fulvic acid with antibiotics has been proved to be effective and safe. Systemic and topical safety of CHD-FA™ in animals and humans was also studied and found to be safe as well as effective against various bacterial and fungal strains. CHD-Fulvic Acid™ provided the added benefit when used with antibiotics. 
In conclusion, when your doctor prescribes an antibiotic course, you can be certain that continuing with your CHD-FA™ supplement is safe. In-fact the great news is that CHD-FA™ will make your antibiotics more effective. Not to mention the myriad of other positive effects of CHD-Fulvic Acid™, such as the absorption of minerals and immune-boosting properties which are essential in the hustle and bustle of the 21 century.
Follow us on social media to learn more about CHD-FA™ and its excellent healing properties.
1. Fernandes, A. C., Medlen, C. E. and Leivers, S. 2009. Fulvic acid and antibiotic combination. International Patent Publication. Patent No. WO2009147635A1. Publication date 12th, 10 2009.
2. Warn, P. 2009. Assessment of the In vitro efficacy of CHD-FA (carbohydrate derived – fulvic acid) +/- Oxacillin following several passages in Methicillin Resistant Staphylococcus Aureus (EMRSA16). Euprotec Report for Fulhold Ltd, 29th February, 2009.
3. Sabi, RA (2009); An investigation into the topical and systemic safety and efficacy of a new carbohydrate derived fulvic acid (CHD-FA) product; Dissertation (MSc)- University of Pretoria, 2009.